Entinostat Active Not Recruiting Phase 2 Trials for Bladder Cancer Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03978624Window of Opportunity Study of Pembrolizumab Alone and in Combinations in Bladder Cancer